Heterogeneous reallocation of presynaptic efficacy in recurrent excitatory circuits adapting to inactivity

Nature Neuroscience

Volumn 15, Issue 2, 2012, Pages 250-257

  Mitra, Ananya ^a   Mitra, Siddhartha S ^a   Tsien, Richard W ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; ROSCOVITINE; TETRODOTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DENDRITIC SPINE; ENZYME INHIBITION; HIPPOCAMPAL CA3 REGION; NERVE CELL NETWORK; NONHUMAN; PRESYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTIC TRANSMISSION; THREE DIMENSIONAL IMAGING;

ADAPTATION, PHYSIOLOGICAL; ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; BIOPHYSICAL PROCESSES; CYCLIN-DEPENDENT KINASE 5; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FEEDBACK, PHYSIOLOGICAL; FORSKOLIN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; NERVE FIBERS; NERVE NET; NERVE TISSUE PROTEINS; NEURONS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PRESYNAPTIC TERMINALS; PROTEIN KINASE INHIBITORS; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; TETRODOTOXIN;

EID: 84856259585     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3004     Document Type: Article

References (50)

1. Silberberg, G., Grillner, S., LeBeau, F.E., Maex, R. & Markram, H. Synaptic pathways in neural microcircuits. Trends. Neurosci. 28, 541-551 (2005). (Pubitemid 41316305)
2. Buzsaki, G. Rhythms of the Brain 464 (Oxford University Press, 2006).
3. Wittner, L., Henze, D.A., Zaborszky, L. & Buzsaki, G. Three-dimensional reconstruction of the axon arbor of a CA3 pyramidal cell recorded and filled in vivo. Brain Struct. Funct. 212, 75-83 (2007). (Pubitemid 47036754)
4. Guzowski, J.F., Knierim, J.J. & Moser, E.I. Ensemble dynamics of hippocampal regions CA3 and CA1. Neuron 44, 581-584 (2004). (Pubitemid 39531222)
5. Rolls, E.T. & Kesner, R.P. A computational theory of hippocampal function, and empirical tests of the theory. Prog. Neurobiol. 79, 1-48 (2006).
6. Song, S., Sjostrom, P.J., Reigl, M., Nelson, S. & Chklovskii, D.B. Highly nonrandom features of synaptic connectivity in local cortical circuits. PLoS Biol 3, e68 (2005).
7. Lefort, S., Tomm, C., Floyd Sarria, J.C. & Petersen, C.C. The excitatory neuronal network of the C2 barrel column in mouse primary somatosensory cortex. Neuron 61, 301-316 (2009).
8. Hardingham, N.R. et al. Quantal analysis reveals a functional correlation between presynaptic and postsynaptic efficacy in excitatory connections from rat neocortex. J. Neurosci. 30, 1441-1451 (2010).
9. Bushey, D., Tononi, G. & Cirelli, C. Sleep and synaptic homeostasis: structural evidence in Drosophila. Science 332, 1576-1581 (2011).
10. Butz, M., van Ooyen, A. & Worgotter, F. A model for cortical rewiring following deafferentation and focal stroke. Front. Comput. Neurosci. 3, 10 (2009).
11. Turrigiano, G.G., Leslie, K.R., Desai, N.S., Rutherford, L.C. & Nelson, S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892-896 (1998). (Pubitemid 28157666)
12. O'Brien, R.J. et al. Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron 21, 1067-1078 (1998). (Pubitemid 29018076)
13. Aoki, C. et al. Drebrin a knockout eliminates the rapid form of homeostatic synaptic plasticity at excitatory synapses of intact adult cerebral cortex. J. Comp. Neurol. 517, 105-121 (2009).
14. Bacci, A. et al. Chronic blockade of glutamate receptors enhances presynaptic release and downregulates the interaction between synaptophysin-synaptobrevin vesicle-associated membrane protein 2. J. Neurosci. 21, 6588-6596 (2001). (Pubitemid 32781103)
15. Burrone, J., O'Byrne, M. & Murthy, V.N. Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons. Nature 420, 414-418 (2002). (Pubitemid 35415651)
16. Thiagarajan, T.C., Lindskog, M. & Tsien, R.W. Adaptation to synaptic inactivity in hippocampal neurons. Neuron 47, 725-737 (2005). (Pubitemid 41208010)
17. Lindskog, M. et al. Postsynaptic GluA1 enables acute retrograde enhancement of presynaptic function to coordinate adaptation to synaptic inactivity. Pro.c Natl. Acad. Sci. USA 107, 21806-21811 (2010).
18. Jakawich, S.K. et al. Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis. Neuron 68, 1143-1158 (2010).
19. Beique, J.C., Na, Y., Kuhl, D., Worley, P.F. & Huganir, R.L. Arc-dependent synapse-specific homeostatic plasticity. Proc. Natl. Acad. Sci. USA 108, 816-821 (2011).
20. Buonomano, D.V. A learning rule for the emergence of stable dynamics and timing in recurrent networks. J. Neurophysiol. 94, 2275-2283 (2005). (Pubitemid 41324658)
21. Houweling, A.R., Bazhenov, M., Timofeev, I., Steriade, M. & Sejnowski, T.J. Homeostatic synaptic plasticity can explain post-traumatic epileptogenesis in chronically isolated neocortex. Cereb. Cortex 15, 834-845 (2005). (Pubitemid 40696122)
22. Kim, J. & Tsien, R.W. Synapse-specific adaptations to inactivity in hippocampal circuits achieve homeostatic gain control while dampening network reverberation. Neuron 58, 925-937 (2008). (Pubitemid 351842756)
23. Maffei, A. & Turrigiano, G.G. Multiple modes of network homeostasis in visual cortical layer 2/3. J. Neurosci. 28, 4377-4384 (2008).
24. Desai, N.S., Rutherford, L.C. & Turrigiano, G.G. Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nat. Neurosci. 2, 515-520 (1999). (Pubitemid 30491231)
25. Trasande, C.A. & Ramirez, J.M. Activity deprivation leads to seizures in hippocampal slice cultures: is epilepsy the consequence of homeostatic plasticity? J. Clin. Neurophysiol. 24, 154-164 (2007). (Pubitemid 46588236)
26. Maffei, A., Nataraj, K., Nelson, S.B. & Turrigiano, G.G. Potentiation of cortical inhibition by visual deprivation. Nature 443, 81-84 (2006). (Pubitemid 44344051)
27. Muller, D., Buchs, P.A. & Stoppini, L. Time course of synaptic development in hippocampal organotypic cultures. Brain Res. Dev. Brain Res. 71, 93-100 (1993). (Pubitemid 23034297)
28. De Simoni, A., Griesinger, C.B. & Edwards, F.A. Development of rat CA1 neurones in acute versus organotypic slices: role of experience in synaptic morphology and activity. J. Physiol. 550, 135-147 (2003). (Pubitemid 36869275)
29. Turrigiano, G.G. & Nelson, S.B. Hebb and homeostasis in neuronal plasticity. Curr. Opin. Neurobiol. 10, 358-364 (2000). (Pubitemid 30389303)
30. Saviane, C. & Silver, R.A. Estimation of quantal parameters with multiple-probability fluctuation analysis. Methods Mol. Biol. 403, 303-317 (2007).
31. Graf, E.R., Daniels, R.W., Burgess, R.W., Schwarz, T.L. & DiAntonio, A. Rab3 dynamically controls protein composition at active zones. Neuron 64, 663-677 (2009).
32. Moulder, K.L. et al. A specific role for Ca2+-dependent adenylyl cyclases in recovery from adaptive presynaptic silencing. J. Neurosci. 28, 5159-5168 (2008).
33. Ma, L., Zablow, L., Kandel, E.R. & Siegelbaum, S.A. Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures. Nat. Neurosci. 2, 24-30 (1999). (Pubitemid 30488936)
34. Su, S.C. & Tsai, L.H. Cyclin-dependent kinases in brain development and disease. Annu. Rev. Cell Dev. Biol. 27, 465-491 (2011).
35. Lai, K.O. & Ip, N.Y. Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim. Biophys. Acta 1792, 741-745 (2009).
36. Kim, S.H. & Ryan, T.A. CDK5 serves as a major control point in neurotransmitter release. Neuron 67, 797-809 (2010).
37. Tomizawa, K. et al. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 2590-2597 (2002). (Pubitemid 37465808)
38. Tsai, L.H., Delalle, I., Caviness, V.S. Jr. Chae, T. & Harlow, E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423 (1994). (Pubitemid 24302556)
39. Meijer, L. et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536 (1997). (Pubitemid 27060443)
40. Yan, Z., Chi, P., Bibb, J.A., Ryan, T.A. & Greengard, P. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J. Physiol. 540, 761-770 (2002). (Pubitemid 35190150)
41. Tao, L., Cai, D., McLaughlin, D.W., Shelley, M.J. & Shapley, R. Orientation selectivity in visual cortex by fluctuation-controlled criticality. Proc. Natl. Acad. Sci. USA 103, 12911-12916 (2006). (Pubitemid 44298660)
42. Fu, W.Y. et al. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat. Neurosci. 10, 67-76 (2007).
43. Tan, T.C. et al. Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 5, 701-710 (2003). (Pubitemid 36986777)
44. Park, M. et al. CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits. Neuron 70, 742-757 (2011).
45. Darcy, K.J., Staras, K., Collinson, L.M. & Goda, Y. Constitutive sharing of recycling synaptic vesicles between presynaptic boutons. Nat. Neurosci. 9, 315-321 (2006). (Pubitemid 43290960)
46. Ou, C.Y. et al. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell 141, 846-858 (2010).
47. Hanson, J.E. & Madison, D.V. Imbalanced pattern completion versus separation in cognitive disease: network simulations of synaptic pathologies predict a personalized therapeutics strategy. BMC Neurosci. 11, 96 (2010).
48. Hanson, J.E., Blank, M., Valenzuela, R.A., Garner, C.C. & Madison, D.V. The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome. J. Physiol. 579, 53-67 (2007).
49. Costa, A.C., Stasko, M.R., Schmidt, C. & Davisson, M.T. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1). Behav. Brain Res. 206, 52-62 (2010).
50. Krystof, V. & Uldrijan, S. Cyclin-dependent kinase inhibitors as anticancer drugs. Curr. Drug Targets 11, 291-302 (2010).